2019 | News | MRC Clinical Trials Unit at UCL

ICON8 trial shows having chemotherapy every week is no better than having it every three weeks for ovarian cancer

Results from the ICON8 trial show that, for women with ovarian cancer, having chemotherapy every week is no better at preventing the cancer coming back or getting worse than having it every three weeks.

02 Dec 2019

Join our RADICALS and ARTISTIC Twitter Q&A #ProstateRadiotherapy

On Thursday 28 November 2019, we'll be running a Twitter Q&A session about the RADICALS trial and the ARTISTIC meta-analysis - with the hashtag #ProstateRadiotherapy. The purpose of the Twitter Q&A is to raise awareness of prostate cancer research. Prostate cancer accounts for around one fifth of all male cancers. In the UK there are around 47,000 new cases each year ...

21 Nov 2019

The 50th Union World Conference on Lung Health

MRC CTU at UCL staff to present analyses from the STREAM tuberculosis trial

30 Oct 2019

STAMPEDE provides further insight into treating prostate cancer

Further results from the STAMPEDE trial have been presented at European Society for Medical Oncology Congress 2019 over the last few days

30 Sep 2019

Active observation still the best treatment for kidney cancer patients at medium or high risk of their cancer coming back after surgery

SORCE recruited 1711 patients with kidney cancer after they had surgery to remove their cancer.

28 Sep 2019

Latest News